503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-39.87%
Negative net income growth while CRWV stands at 7.67%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
12.85%
Less D&A growth vs. CRWV's 26.15%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-143.82%
Negative yoy deferred tax while CRWV stands at 3.70%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-0.82%
Both cut yoy SBC, with CRWV at -21.18%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
402.45%
Slight usage while CRWV is negative at -110.52%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
169.81%
AR growth while CRWV is negative at -35.57%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-100.00%
Negative yoy inventory while CRWV is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-100.00%
Both negative yoy AP, with CRWV at -663.96%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-30.43%
Negative yoy usage while CRWV is 112.72%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
83.77%
Well above CRWV's 23.14%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
48.78%
Some CFO growth while CRWV is negative at -510.76%. John Neff would note a short-term liquidity lead over the competitor.
-8.51%
Both yoy lines negative, with CRWV at -74.30%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-126.98%
Negative yoy acquisition while CRWV stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-161.65%
Negative yoy purchasing while CRWV stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
11.55%
We have some liquidation growth while CRWV is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
100.00%
Less 'other investing' outflow yoy vs. CRWV's 202.79%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-6317.39%
Both yoy lines negative, with CRWV at -70.42%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
18.80%
We repay more while CRWV is negative at -200.00%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
339.58%
Stock issuance far above CRWV's 4.88%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
47.69%
Buyback growth of 47.69% while CRWV is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.